

Mar 5, 2022
Rampathon 2022 - Building wheelchair access ramps in King and Snohomish Counties for free.

Mar 3, 2022
Fulcrum Therapeutics, Inc. announced its plans to initiate REACH, a Phase 3 clinical trial of losmapimod in people with FSHD, in the second quarter of 2022.

Mar 1, 2022
Dr. Hiramuki provides a final project update.
Connect with us on social media